Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-12 Purchase | 2024-12-16 4:26 pm | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 131,800 | $2.9269 | $385,769 | 5,357,347 (Indirect) | View |
| 2024-11-25 Purchase | 2024-11-27 6:11 pm | Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner | 456,353 | $0.62346 | $284,520 | 8,883,308 (Indirect) | View |
| 2024-11-15 Purchase | 2024-11-19 4:26 pm | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 947 | $4.3442 | $4,114 | 5,225,547 (Indirect) | View |
| 2023-05-31 Sale | 2023-06-02 5:35 pm | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 25,400 | $2.5178 | $63,953 | 5,224,600 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-08-09 5:11 pm | N/A N/A | Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner | 0 | $0 | 8,426,955 (Indirect) | View |
Ownership | 2023-06-02 5:33 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 0 | $0 | 5,250,000 (Indirect) | View |